Covid Drugs

DRDO Issues Directions For Use Of Anti-Covid Drug 2-DG

The Defence Research and Development Organisation (DRDO) on Tuesday issued directions on how to use the new drug called 2-DG for Covid patients. The patients under the care and prescription…

View Post

MSN Labs Enters Into Licensing Agreement With Lilly To Launch Baricitinib In India For COVID 19

MSN Labs (MSN) has announced today that they have entered into a royalty free, non-exclusive, voluntary license agreement with Eli Lilly and Company of USA for manufacturing and marketing of…

View Post

Study Identifies Possible Covid Drugs

A team of researchers has identified nine potential new Covid-19 treatments, including three, that was already approved by the US Food and Drug Administration(FDA) for treating other diseases. The study,…

View Post

Phase 2a Trial Of COVID-19 Therapeutic Molnupiravir Show Promising Results

Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics, LP have announced preliminary results from Ridgeback’s Phase 2a randomized, double-blind, placebo-controlled trial to evaluate the safety,…

View Post

US’ National Institutes Of Health (NIH) Halts Trial Of Covid-19 Convalescent Plasma

The US’ National Institutes of Health (NIH) has halted a clinical trial evaluating the safety and effectiveness of COVID-19 convalescent plasma in treating emergency department patients who developed mild to…

View Post

Names Of Best Selling COVID-19 Vaccines And Drugs Revealed

AllianceBernstein’s Sanford C. Bernstein unit has revealed the names of the top 7 best-selling COVID-19 vaccines and drugs of 2020. After the analysis of sales figures released in recent weeks…

View Post

Spotlight

Sanofi Announces To Stop Trials of Covid-19 Drug After Tests

French Pharma giant Sanofi has announced that it is stopping clinical trials of Kevzara drug for serious Covid-19 cases. Only recently, the drug had entered the international Phase 3 clinical…

View Post

Menu

Covid Drugs

DRDO Issues Directions For Use Of Anti-Covid Drug 2-DG

MSN Labs Enters Into Licensing Agreement With Lilly To Launch Baricitinib In India For COVID 19

Study Identifies Possible Covid Drugs

Phase 2a Trial Of COVID-19 Therapeutic Molnupiravir Show Promising Results

US’ National Institutes Of Health (NIH) Halts Trial Of Covid-19 Convalescent Plasma

Names Of Best Selling COVID-19 Vaccines And Drugs Revealed

Sanofi Announces To Stop Trials of Covid-19 Drug After Tests

Flesh-Eating Ulcer Cases Surge in Australia: Health Authorities Issue Warning

Epigamia Co-Founder Rohan Mirchandani Passes Away at 42 Due to Cardiac Arrest: Key Risk Factors and Warning Signs for Men in Their 40s

Does the 2022 H5N1 Virus Bind and Replicate Better in the Human Respiratory Tract? Here’s The Truth

Walking Speed Is An Indicator of Metabolic Health in Obese Individuals: Study Reveals

First-Ever Blood-Stage Malaria Vaccine Shows Promising Results in Phase IIb Trial

FDA Moves to Restrict Psychoactive Mushrooms Used in Edibles Amid Growing Concerns

Revolutionary CAR-T Cell Therapy Developed by AIIMS Researchers Offers New Hope for Multiple Myeloma Patients

Severe Strain of Bird Flu Spreading Rapidly: Is India at Risk of Another Pandemic?